Multifunctional protease inhibitors and their use in treatment of disease

Details for Australian Patent Application No. 2002241661 (hide)

Owner Arriva Pharmaceuticals, Inc

Inventors Pemberton, Philip; Barr, Philip J.; Gibson, Helen L.

Agent FB Rice

Pub. Number AU-B-2002241661

PCT Pub. Number WO02/50287

Priority 60/256,699 18.12.00 US; 60/331,966 20.11.01 US

Filing date 18 December 2001

Wipo publication date 1 July 2002

Acceptance publication date 31 May 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 27/16 (2006.01) Drugs for disorders of the senses

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/99 (2006.01) Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

C12N 15/15 (2006.01) Mutation or genetic engineering - Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

31 May 2007 Application Accepted

  Published as AU-B-2002241661

27 September 2007 Standard Patent Sealed

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002241662-APPARATUS AND METHODS FOR FINGER DELAY SELECTION IN RAKE RECEIVERS

2002241660